from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1308/atpA

LFCtreatmentdescriptionclass of inhibitor

-2.106

Amikacinug/mL Amikacintranslation

-2.224

Cap5-10ug/mL Capreomycintranslation

-2.651

Rox10-50 ug/mL Roxithromycintranslation

-0.606

SM2-5 ug/mL Streptomycintranslation

-3.119

Tet5-10 ug/mL Tetracyclinetranslation

-1.033

Rif0.2-5ug/mL Rifampicintranscription

-1.618

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.278

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.784

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.523

CPZ10-50 ug/mL Chlorpromazinerespiration

0.388

Clofazimine10-13 ug/mL Clofaziminerespiration

0.461

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.286

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.734

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.039

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.189

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.845

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.944

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.843

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.071

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.136

KCN5-20 ug/mL Potassium cyaniderespiration

0.718

NaN30.2-2 mM Sodium aziderespiration

0.724

Nigericin50 uM Nigericinrespiration

-0.685

TRC10-150 ug/mL Triclosanrespiration

0.526

TRZ10-25 ug/mL Thioridazinerespiration

-1.258

Valinomycin0.5-10 uM Valinomycinrespiration

0.358

ZnSO42 mM ZnSO4respiration

-0.931

menadione6-10 ug/mL Menadionerespiration

0.079

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.368

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.675

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.390

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.622

NRP_1Non-replicating persistence stage 1dosRassociated

0.712

Amp0.2mg/mL AmpicillincellWall

0.702

Cephalexin20-100 ug/mL CephalexincellWall

0.062

Cerulenin0.32-5 ug/mL CerulenincellWall

0.409

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.097

EMB10-20 ug/mL EthambutolcellWall

0.454

Eta12-40 ug/mL EthionamidecellWall

0.911

INH0.2-0.4 ug/mL IsoniazidcellWall

0.367

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.448

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.102

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.347

BZA0.12 mg/mL BenzamidearomaticAmides

-0.263

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.283

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.146

H2O24 mM hydrogen peroxideDNAdamaging

-0.169

Levo10 ug/mL LevofloxacinDNAdamaging

1.011

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.778

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.081

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.759

UVUV-irradiationDNAdamaging

0.590

ARP41-4 ug/mL Antitubercular compound ARP4?

0.267

Antimycin12.5-50 ug/mL Antimycin A?

0.320

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.081

PA_110-50 ug/mL Antitubercular compound PA-1?

0.229

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.248

PA8240.2-2 ug/mL PA-824?

0.061

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.754

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.218

Verapamil50 uM Verapamil?

0.486

mercaptoethanol2 mM 2-Mercaptoethanol?

0.504

methoxatin10-20 ug/mL Methoxatin?